- Report
- June 2025
- 181 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 576 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- May 2025
- 750 Pages
Global
From €3578EUR$3,995USD£3,050GBP
- Report
- May 2025
- 192 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 183 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 182 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 187 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 184 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- April 2025
- 170 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- November 2024
- 190 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- May 2025
- 182 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 185 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 197 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 190 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 250 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- November 2024
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP

The Liposome market is a subset of the Drug Delivery market, which focuses on the development of technologies to deliver drugs to their intended targets. Liposomes are microscopic vesicles composed of phospholipids, which are used to encapsulate drugs and deliver them to the desired location in the body. Liposomes are advantageous due to their ability to protect drugs from degradation, increase drug solubility, and target specific cells.
Liposome-based drug delivery systems are used in a variety of therapeutic areas, including oncology, infectious diseases, and cardiovascular diseases. Liposomes are also used in the development of vaccines, as they can be used to deliver antigens to the body and induce an immune response.
Notable companies in the Liposome market include Lipoxen Technologies, Lipomed, and Liposome Company. Other companies in the market include Avanti Polar Lipids, Bio-Techne, and InnoBio. Show Less Read more